#NSMC #NephJC #GlomCon #ISNKidneyCare
@SayaliBThakare
Welcome to #TenPostNephJC
Last #NephJC we discussed about AHA/ACC 2025 Hypertension guidelines: PREVENT, Detect, Treat
Didn’t catch the pulse of this one? No worries we’ll help you pressure check the 2025 AHA Hypertension Guidelines. ❤ #AHA2025
www.ahajournals.org/doi/10.1161/...
Welcome to #TenPostNephJC
Last #NephJC we discussed about AHA/ACC 2025 Hypertension guidelines: PREVENT, Detect, Treat
Didn’t catch the pulse of this one? No worries we’ll help you pressure check the 2025 AHA Hypertension Guidelines. ❤ #AHA2025
www.ahajournals.org/doi/10.1161/...
Join the discussion 9/30/25 at 9 pm EST on Bluesky #NephSky #MedSky #NephJC
www.nephjc.com/news/chimera-tolerance-njqe334
Join the discussion 9/30/25 at 9 pm EST on Bluesky #NephSky #MedSky #NephJC
www.nephjc.com/news/chimera-tolerance-njqe334
Join use only on #Bluesky on 9/16/25 at 9pm EST.
We're discussing the 2025 ACC/AHA Hypertension Guideline Update. 🫀🫘🧠 #NephSky #MedSky
www.nephjc.com/news/accaha2025-klno3
Join use only on #Bluesky on 9/16/25 at 9pm EST.
We're discussing the 2025 ACC/AHA Hypertension Guideline Update. 🫀🫘🧠 #NephSky #MedSky
www.nephjc.com/news/accaha2025-klno3
We will discuss the use of spironolactone in patients on dialysis to prevent t cardiovascular outcomes and heart failure hospitalizations.
Invite your friends. #NephJC #NephSky
www.nephjc.com/news/achieve
www.nephjc.com/news/2025/8/...
www.nephjc.com/news/2025/8/...
Submit your abstract here: isn-india.org/isn_registra...
@jasminenephro.bsky.social
@sayalibthakare.bsky.social
@thisis-drgsp2.bsky.social
@arvindcanchi.bsky.social
Submit your abstract here: isn-india.org/isn_registra...
@jasminenephro.bsky.social
@sayalibthakare.bsky.social
@thisis-drgsp2.bsky.social
@arvindcanchi.bsky.social
🔗 Submit your abstract here: isn-india.org/isn_registra...
@sayalibthakare.bsky.social
@thisis-drgsp2.bsky.social
@jasminenephro.bsky.social
🔗 Submit your abstract here: isn-india.org/isn_registra...
@sayalibthakare.bsky.social
@thisis-drgsp2.bsky.social
@jasminenephro.bsky.social
Donate your organs and save lives.
Pledge your organs here 👉 pledge.mygov.in/organ-donation
@kajareeg.bsky.social
@sayalibthakare.bsky.social
@thisis-drgsp2.bsky.social
@jasminenephro.bsky.social
@arvindcanchi.bsky.social
Donate your organs and save lives.
Pledge your organs here 👉 pledge.mygov.in/organ-donation
@kajareeg.bsky.social
@sayalibthakare.bsky.social
@thisis-drgsp2.bsky.social
@jasminenephro.bsky.social
@arvindcanchi.bsky.social
Annually more than a million people die of TB
Overall, more than a *billion* people have died of TB in last 2 centuries
That’s also something like 1 in 7 people who have ever lived 🤯
#NephJCBookClub
Annually more than a million people die of TB
Overall, more than a *billion* people have died of TB in last 2 centuries
That’s also something like 1 in 7 people who have ever lived 🤯
#NephJCBookClub
Join us 9 pm EST 8/5/25 to discuss. #NephJC #NephSky
Controlling Phos in patients on HD is a lot of work, but is it worth it? HiLo looks at hospitalization & death in low/high Phos goals. Will we finally have a RCT with answers ⁉️
www.nephjc.com/news/hilo-tr...
Join us 9 pm EST 8/5/25 to discuss. #NephJC #NephSky
Controlling Phos in patients on HD is a lot of work, but is it worth it? HiLo looks at hospitalization & death in low/high Phos goals. Will we finally have a RCT with answers ⁉️
www.nephjc.com/news/hilo-tr...
Beat the deadline ‼️ Submit your abstract NOW at www.isncon2025.com
@sayalibthakare.bsky.social @thisis-drgsp2.bsky.social @kajareeg.bsky.social
@arvindcanchi.bsky.social
Beat the deadline ‼️ Submit your abstract NOW at www.isncon2025.com
@sayalibthakare.bsky.social @thisis-drgsp2.bsky.social @kajareeg.bsky.social
@arvindcanchi.bsky.social
This case report from Drs Sultan, @sayalibthakare.bsky.social, Tukaram Jamale et al is evidence of that!
www.tandfonline.com/doi/full/10....
This case report from Drs Sultan, @sayalibthakare.bsky.social, Tukaram Jamale et al is evidence of that!
www.tandfonline.com/doi/full/10....
Abstract submission closes 31st July 2025
Submit your abstracts NOW 👉 isn-india.org/isn_registra...
@priti899.bsky.social
@sayalibthakare.bsky.social @thisis-drgsp2.bsky.social
#Lucknow bula raha hain
Abstract submission closes 31st July 2025
Submit your abstracts NOW 👉 isn-india.org/isn_registra...
@priti899.bsky.social
@sayalibthakare.bsky.social @thisis-drgsp2.bsky.social
#Lucknow bula raha hain
Abstract submission closes on 31st July 2025.
Submit your abstracts NOW 👉 isn-india.org/isn_registra...
@kajareeg.bsky.social @sayalibthakare.bsky.social @thisis-drgsp2.bsky.social
Abstract submission closes on 31st July 2025.
Submit your abstracts NOW 👉 isn-india.org/isn_registra...
@kajareeg.bsky.social @sayalibthakare.bsky.social @thisis-drgsp2.bsky.social
Doing a great job here Akshaya! 👍🏻
@nephromommy-akshu.bsky.social
Doing a great job here Akshaya! 👍🏻
@nephromommy-akshu.bsky.social
#NephSky #MedSky join us for a lively discussion.
We're debating eGFRdiff (the gap that is sometimes present between the eGFR of cystatin C and creatinine). What does it mean, what causes it and what you should do about it. #NephJC
www.nephjc.com/news/egfrdiff
#NephSky #MedSky join us for a lively discussion.
We're debating eGFRdiff (the gap that is sometimes present between the eGFR of cystatin C and creatinine). What does it mean, what causes it and what you should do about it. #NephJC
www.nephjc.com/news/egfrdiff
#Nephsky #NephJC
www.nephjc.com/news/cricdiff
#Nephsky #NephJC
www.nephjc.com/news/cricdiff
🔍 What drives eGFRdiff? They tested for 3 groups.
FYI!
Shrunken Pore Syndrome: Reduced filtering of larger molecules (5-30 kDa). Diagnosed when eGFRcys is < 60% of eGFRcr. Risk for mortality, CVD and contrast nephropathy. Associated with ⬆️BMI, T2DM, HTN.
What else did they miss? #NephJC
🔍 What drives eGFRdiff? They tested for 3 groups.
FYI!
Shrunken Pore Syndrome: Reduced filtering of larger molecules (5-30 kDa). Diagnosed when eGFRcys is < 60% of eGFRcr. Risk for mortality, CVD and contrast nephropathy. Associated with ⬆️BMI, T2DM, HTN.
What else did they miss? #NephJC
Last #NephJC we discussed the combination therapy of empagliflozin and finerenone 💊 #TenPostNephJC
🌵From a therapeutic dessert to a flood of options in diabetic kidney disease (DKD) - what is the best timing to keep the kidneys afloat
Last #NephJC we discussed the combination therapy of empagliflozin and finerenone 💊 #TenPostNephJC
🌵From a therapeutic dessert to a flood of options in diabetic kidney disease (DKD) - what is the best timing to keep the kidneys afloat
Register NOW 👉 www.isncon2025.com
@kajareeg.bsky.social @thisis-drgsp2.bsky.social @sayalibthakare.bsky.social
Register NOW 👉 www.isncon2025.com
@kajareeg.bsky.social @thisis-drgsp2.bsky.social @sayalibthakare.bsky.social
#NephJC summary by @sejalplakhani.bsky.social and @jeyakumarmeyyappan.bsky.social
#MedSky
www.nephjc.com/news/confide...
#NephJC summary by @sejalplakhani.bsky.social and @jeyakumarmeyyappan.bsky.social
#MedSky
www.nephjc.com/news/confide...
⏰Chat happening on July 8, 9 pm EST
www.nephjc.com/news/2025/7/...
⏰Chat happening on July 8, 9 pm EST
www.nephjc.com/news/2025/7/...
@kajareeg.bsky.social @isn-india.bsky.social @sayalibthakare.bsky.social @thisis-drgsp2.bsky.social
@kajareeg.bsky.social @isn-india.bsky.social @sayalibthakare.bsky.social @thisis-drgsp2.bsky.social
www.nephjc.com
www.nephjc.com